What changed: Oropharyngeal cancer (tonsil and base of tongue)
Every dated change on the records linked to Oropharyngeal cancer (tonsil and base of tongue), newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.
Trial result5Milestone5This record1
September 2026 · 1
2019 · 5
- 2019Trial resultDe-ESCALaTE HPVDe-ESCALaTE HPV reported
Severe toxicity similar; 2-year overall survival 97.
- 2019Trial resultKEYNOTE-048KEYNOTE-048 reported
OS 14.
- 2019Trial resultRTOG 1016RTOG 1016 reported
5-year overall survival 84.
- 2019MilestoneKEYNOTE-048Pembrolizumab first line in recurrent disease (KEYNOTE-048)
A milestone in how this cancer is treated.
- 2019MilestoneRTOG 1016RTOG 1016 and De-ESCALaTE: cetuximab inferior to cisplatin
A milestone in how this cancer is treated.